Phencyclidine and corticosteroids induce apoptosis of a subpopulation of striatal neurons: A neural substrate for psychosis?

Neuroscience

Volumn 84, Issue 2, 1998, Pages 489-501

  Mitchell, I J ^a   Cooper, A J ^a   Griffiths, M R ^a   Barber, D J ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Dopamine; Enkephalin; Huntington's disease; PCP; Psychosis; Striatum

Indexed keywords

COLLOIDAL GOLD; CORTICOSTEROID; DEXAMETHASONE; DOPAMINE; METHENAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHENCYCLIDINE; PROPIDIUM IODIDE;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; FLUORESCENCE; HISTOCHEMISTRY; HUNTINGTON CHOREA; MALE; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; PSYCHOSIS;

ANIMALS; APOPTOSIS; BRAIN; CORPUS STRIATUM; DEXAMETHASONE; GLUCOCORTICOIDS; MALE; NEURONS; ORGAN SPECIFICITY; PHENCYCLIDINE; PSYCHOTIC DISORDERS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031912446     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00534-4     Document Type: Article

References (69)

1. Albin R. L., Reiner A., Anderson K. D., Dure L. S., Handelin B., Balfour R., Whetsell W. O., Penney J. B., Young A. B. Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease. Ann. Neurol. 31:1992;425-430.
2. Alexander G. E., Delong M. R., Strick P. L. Parallel organisation of functionally segregated circuits linking basal ganglia and cortex. A. Rev. Neurosci. 9:1986;357-381.
3. Beal M. F., Kowall N. W., Ellison D. W., Mazurek M. F., Swartz K. J., Martin J. B. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature. 321:1986;168-171.
4. Berendse H. W., Galis-de Graaf Groenewegen H. J. The topographical organization and relationship with ventral striatal compartments of prefrontal corticostriatal projections in the rat. J. comp. Neurol. 316:1992;314-347.
5. Brouillet L., Hantraye P., Ferrante R. J., Dolan R., Leroy-Willig A., Kowall N. W., Beal M. F. Chronic mitochondrial impairment produces selective striatal degeneration and abnormal choreiform movements in primates. Proc. natn. Acad. Sci. U.S.A. 92:1995;7105-7109.
6. Chao H. M., Choo P. H., McEwen B. S. Glucocorticoid and mineralocorticoid receptor mRNA expression in rat brain. Neuroendocrinology. 50:1989;365-371.
7. 2 antagonist induce apoptosis of a sub-population of striatal neurons. Brain Res. Assoc. Abstr. 14:1997;58.
8. Cooper A. J., Moser B., Mitchell I. J. A subset of striatopallidal neurons are Fos-immunopositive following acute monoamine depletion in the rat. Neurosci. Lett. 187:1995;189-192.
9. Date I. Parkinson's disease, trophic factors, and adrenal medullary chromaffin cell grafting: basic and clinical studies. Brain Res. Bull. 40:1996;1-19.
10. Davison K., Bagley C. R. Schizophrenia-like psychoses associated with organic cerebral disorders - A review. Psychiat. Developments. 1:1969;1-34.
11. Dawbarn D., Dequidt M. E., Emson P. C. Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease. Brain Res. 340:1985;251-260.
12. Deroche V., Piazza P. V., Maccari S., Le Moal M., Simon H. Repeated corticosterone administration sensitizes the locomotion response to amphetamine. Brain Res. 584:1992;309-313.
13. Devinsky O., Morrell M. J., Vogt B. A. Contributions of anterior cingulate cortex to behaviour. Brain. 118:1995;279-306.
14. Diorio D., Viau V., Meaney M. J. The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress. J. Neurosci. 13:1993;3847-3859.
15. Eisch A. J., Gaffney M., Weihmuller F. B., O'Dell S. J., Marshall J. F. Striatal subregions are differentially vulnerable to the neurotoxic effects of methamphetamine. Brain Res. 598:1992;321-326.
16. Ellison G. Competitive and non-competitive NMDA antagonists induce similar limbic degeneration. NeuroReport. 5:1994;2688-2692.
17. Ellison G. The NMDA antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias. Brain Res. Rev. 20:1995;250-267.
18. Ferrante R. J., Kowall N. W., Beal N. W., Richardson E. P., Bird E. D. Selective sparing of a class of striatal interneurons in Huntington's disease. Science. 230:1985;561-564.
19. Fix A. S., Wozniak D. F., Truex L. L., McEwen M., Miller J. P., Olney J. W. Quantitative analysis of factors influencing neuronal necrosis induced by MK-801 in the rat posterior cingulate/retrosplenial cortex. Brain Res. 696:1995;194-204.
20. Gerfen C. R. The neostriatal mosaic: multiple levels of compartmental organisation. Trends Neurosci. 15:1992;133-139.
21. Gray J. A., Feldon J., Rawlins J. N. P., Hemsley D. R., Smith A. D. The neuropsychology of schizophrenia. Behav. Brain Sci. 14:1991;1-84.
22. Graybiel A. M. Neurotransmitters and neuromodulation in the basal ganglia. Trends Neurosci. 13:1990;244-258.
23. Griffiths M. R., Stockwell T., Barber D. J., Cooper A. J., Mitchell I. J. Striatal apoptosis induced by acute administration of phencyclidine is potentiated by coadministration of dexamethasone. Brain Res. Assoc. Abstr. 14:1997;75.
24. Hamamura T., Ichimara Y., Fibiger H. C. Amphetamine sensitization enhances regional c-fos expression produced by conditioned fear. Neuroscience. 76:1997;1097-1103.
25. Handa R. J., Nunley K. M., Bollnow M. R. Induction of c-fos mRNA in the brain and anterior pituitary gland by a novel environment. NeuroReport. 4:1993;1079-1082.
26. 1 receptors to striatonigral neurons. Brain Res. 528:1990;317-322.
27. Hashimoto K., Tomitaka S., Narita N., Minabe Y., Iyo M., Fukui S. Induction of heat shock protien (HSP)-70 in posterior cingulate and retrosplenial cortex of rat brain by dizocilpine and phencyclidine: lack of protective effects of sigma receptor ligands. Addict. Biol. 1:1996;61-70.
28. Hastings T. G., Lewis D. A., Zigmond M. J. Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc. natn. Acad. Sci. U.S.A. 93:1996;1956-1961.
29. Hedreen J. C., Folstein S. E. Early loss of neostriatal striosome neurons in Huntington's disease. J. Neuropath. exp. Neurol. 54:1995;105-120.
30. Ismail K., Wessely S. Psychiatric complications of corticosteroid therapy. Br. J. Hospital Med. 53:1995;495-499.
31. Iversen S. D. Interactions between excitatory amino acids and dopamine systems in the forebrain: implications for schizophrenia and Parkinson's disease. Behav. Pharmac. 6:1995;478-491.
32. Jackson D. M., Johansson C., Lindgren L. I., Bengstsson A. Dopamine receptor antagonists block amphetamine and phencyclidine-induced motor stimulation in rats. Pharmac. Biochem. Behav. 48:1994;465-471.
33. Jeffcoate W. J., Silverstone J. T., Edwards C. R. W., Besser G. M. Psychiatric manifestations of Cushing's syndrome: response to lowering of plasma cortisol. Q. Jl med. N.S. 48:1979;465-472.
34. Landwehrmeyer G. B., Standaert D. G., Testa C. M., Penney J. B., Young A. B. NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum. J. Neurosci. 15:1995;5297-5307.
35. Lillrank S. M., O'Connor W. T., Saransaari P., Ungerstedt U. In vivo effects of local and systemic phencyclidine on the extracellular levels of catecholamines and transmitter amino acids in the dorsolateral striatum of anaesthetized rats. Acta physiol. scand. 150:1994;109-115.
36. Kawaguchi Y., Wilson C. J., Augood S. J., Emson P. C. Striatal interneurons: chemical, physiological and morphological characterization. Trends Neurosci. 18:1995;527-535.
37. Kelley A. E., Delfs J. M., Chu B. Neurotoxicity induced by the D-1 agonist SKF38393 following microinjection into rat brain. Brain Res. 532:1990;342-346.
38. Mazars G. Criteria for identifying cingulate epilepsies. Epilepsia. 11:1970;41-47.
39. McGeorge A. J., Faull R. L. M. The organisation of the projection from the cerebral cortex to the striatum in the rat. Neuroscience. 29:1989;503-537.
40. Mena M. A., Pardo B., Casarejos M. J., Fahn S., Yebenes J. G. Neurotoxicity of levodopa on catecholamine-rich neurons. Movement Disord. 7:1992;23-31.
41. Mitchell I. J., Jackson A., Sambrook M. A., Crossman A. R. The role of the subthalamic nucleus in experimental chorea: evidence from 2-deoxyglucose metabolic studies and horseradish peroxidase tracing studies. Brain. 112:1989;1533-1548.
42. Mitchell I. J., Lawson S., Moser B., Laidlaw S. M., Cooper A. J., Walkinshaw G., Waters C. M. Glutamate-induced apoptosis results in a loss of striatal neurons in the Parkinsonian rat. Neuroscience. 63:1994;1-5.
43. Nakki R., Koistinaho J., Sharp F. R., Sagar S. M. Cerebellar toxicity of phencyclidine. J. Neurosci. 15:1995;2097-2108.
44. Nishijima K., Kashiwa A., Hashimoto A., Iwama H., Umino A., Nishikawa T. Differential effects of phencyclidine and methamphetamine on dopamine metabolism in rat frontal cortex and striatum as revealed by in vivo dialysis. Synapse. 22:1996;303-312.
45. Norman R. M. G., Malla A. K. Stressful life events and schizophrenia I: a review of the research. Br. J. Psychiat. 162:1993;161-166.
46. Nuechterlein K. H., Dawson M. E. A heuristic vulnerability-stress model of schizophrenic episodes. Schizophr. Bull. 10:1984;300-312.
47. Olney J. W., Labruyere J., Wang G., Wozniak D. F., Price M. T., Sesma M. A. NMDA antagonist neurotoxicity: mechanism and prevention. Science. 254:1991;1515-1518.
48. Oorschot D. E. Total number of neurons in the neostriatal, pallidal, subthalamic and substantia nigra nuclei of the rat basal ganglia: a stereological study using the Cavalieri and optical disector methods. J. comp. Neurol. 366:1996;580-599.
49. Pauly J. R., Robinson S. F., Collins A. C. Chronic corticosterone administration enhances behavioural sensitization to amphetamine in mice. Brain Res. 620:1993;195-202.
50. Price L. H., Spencer D. D., Marek K. L., Robbins R. J., Leranth C., Farhi A., Naftolin F., Roth R. H., Bunney B. S., Hoffer P. B., Makuch R., Redmond D. E. Psychiatric status after human fetal mesencephalic tissue transplantation in Parkinson's disease. Biol. Psychiat. 8:1995;498-505.
51. Raff M. C., Barres B. A., Burne J. F., Coles H. S., Ishizaki Y., Jacobson M. D. Programmed cell death and the control of cell survival: lesson from the nervous system. Science. 262:1993;695-700.
52. Reiner A., Albin R. L., Anderson K. D., D'Amato C. J., Penney J. B., Young A. B. Differential loss of striatal projection neurons in Huntington's disease. Proc. natn. Acad. Sci. U.S.A. 85:1988;5733-5737.
53. Rots N. Y., Cools A. R., Dejong J., Dekloet E. R. Corticosteroid feedback resistance in rats genetically selected for increased dopamine responsiveness. J. Neuroendocr. 7:1995;153-161.
54. Rouge-Pont F., Marinelli M., Le Moal M., Simon H., Piazza P. V. Stress-induced sensitization and glucocorticoids. II. Sensitization of the increase in extracellular dopamine induced by cocaine depends on stress-induced corticosterone secretion. J. Neurosci. 15:1995;7189-7195.
55. Sapolsky R. M. Glucocorticoid toxicity in the hippocampus: reversal by supplementation with brain fuels. J. Neurosci. 6:1986;2240-2244.
56. Sapolsky R. L., Krey L. C., McEwen B. S. Prolonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging. J. Neurosci. 5:1985;1222-1227.
57. Sharp F. R., Jasper P., Hall J., Noble L., Sagar S. M. MK-801 and ketamine induce heat shock protein HSP70 in injured neurons in cingulate and retrosplenial cortex. Ann. Neurol. 30:1991;801-809.
58. Sharp J. W. PCP and ketamine inhibit non-NMDA glutamate receptor mediated hsp70 induction. Brain Res. 728:1996;215-224.
59. Shinkai T., Zhang S. A., Mathias S. A., Roth G. S. Dopamine induces apoptosis in cultured rat striatal neurons; possible mechanism of D2-dopamine receptor neuron loss during aging. J. Neurosci. Res. 47:1997;393-399.
60. Sonders M. S., Keana J. F. W., Weber E. Phencyclidine and psychomimetic sigma opiates: recent insights into their biochemical and physiological sites of action. Trends Neurosci. 11:1988;37-40.
61. Su T. P., London E. D., Jaffe J. H. Steroid binding at sigma receptors suggests a link between endocrine, nervous and immune systems. Science. 240:1988;219-221.
62. Uno H., Eisele S., Sakai A., Shelton S., Baker E., Dejesus O., Holden J. Neurotoxicity of glucocorticoids in the primate brain. Hormones Behav. 28:1994;336-348.
63. Walkinshaw G., Waters C. M. Neurotoxin induced cell death in neuronal PC12 cells is mediated by induction of apoptosis. Neuroscience. 63:1994;975-987.
64. Walkinshaw G., Waters C. M. Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. J. clin. Invest. 95:1995;2458-2464.
65. Waters C. M., Moser B., Walkinshaw G., Mitchell I. J. Death of neurons in the neonatal rodent and primate globus pallidus occurs by a mechanism of apoptosis. Neuroscience. 63:1994;881-894.
66. Weinberger D. R. Implications of normal brain development for the pathogenesis of schizophrenia. Archs gen. Psychiat. 44:1987;660-669.
67. Wozniak D. F., Brosnan-Watters G., Nardi A., McEwen M., Corso T. D., Olney J. W., Fix A. S. MK-801 neurotoxicity in male mice: histological effects and chronic impairment in spatial learning. Brain Res. 707:1996;165-179.
68. Wyllie A. H. Apoptosis: cell death in tissue regulation. J. Pathology. 153:1987;313-316.
69. Ziv I., Melamed E., Nardi N., Luria D., Achiron A., Offen D., Barzilai A. Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons - a possible novel pathogenetic mechanism in Parkinson's disease. Neurosci. Lett. 170:1994;136-140.